Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Juniper Pharmaceuticals Inc (CBRX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Juniper Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 821995.
Total stock buying since 2014: $928,006.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $1,403,741.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2018 | 0 | $0 | 0 | $0 | 217,000 | $1,357,335 |
| 2017 | 2,000 | $9,638 | 0 | $0 | 0 | $0 |
| 2016 | 18,623 | $109,120 | 0 | $0 | 0 | $0 |
| 2015 | 79,905 | $743,468 | 0 | $0 | 9,375 | $46,406 |
| 2014 | 11,000 | $65,780 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-08 | 0 | $0 | 0 | $0 | 217,000 | $1,357,335 |
| 2017-03 | 2,000 | $9,638 | 0 | $0 | 0 | $0 |
| 2016-09 | 2,000 | $11,930 | 0 | $0 | 0 | $0 |
| 2016-08 | 16,623 | $97,190 | 0 | $0 | 0 | $0 |
| 2015-12 | 1,600 | $19,420 | 0 | $0 | 0 | $0 |
| 2015-11 | 18,000 | $211,517 | 0 | $0 | 0 | $0 |
| 2015-08 | 15,000 | $155,220 | 0 | $0 | 0 | $0 |
| 2015-06 | 35,305 | $283,711 | 0 | $0 | 0 | $0 |
| 2015-05 | 10,000 | $73,600 | 0 | $0 | 9,375 | $46,406 |
| 2014-11 | 1,000 | $5,980 | 0 | $0 | 0 | $0 |
| 2014-08 | 10,000 | $59,800 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-08-14 | Patel Nikin (Chief Operating Officer) | Option Ex | 217,000 | 6.25 | 1,357,335 |
| 2017-03-17 | Geraghty James A (Director) | Buy | 2,000 | 4.82 | 9,638 |
| 2016-09-13 | Geraghty James A (Director) | Buy | 2,000 | 5.96 | 11,930 |
| 2016-08-31 | Elston George (Chief Financial Officer) | Buy | 1,000 | 5.50 | 5,500 |
| 2016-08-26 | Merrifield C Ann (Director) | Buy | 2,000 | 5.63 | 11,260 |
| 2016-08-25 | Secor Alicia (President and CEO) | Buy | 5,000 | 5.75 | 28,750 |
| 2016-08-23 | Armstrong Frank M (Director) | Buy | 1,623 | 6.16 | 9,994 |
| 2016-08-23 | Geraghty James A (Director) | Buy | 2,937 | 6.03 | 17,715 |
| 2016-08-22 | Geraghty James A (Director) | Buy | 4,063 | 5.90 | 23,971 |
| 2015-12-04 | Merrifield C Ann (Director) | Buy | 1,600 | 12.14 | 19,420 |
| 2015-11-19 | Patel Nikin (COO) | Buy | 4,300 | 11.88 | 51,101 |
| 2015-11-18 | Patel Nikin (COO) | Buy | 700 | 11.45 | 8,016 |
| 2015-11-18 | Condella Frank Jr (President & CEO) | Buy | 5,000 | 11.68 | 58,400 |
| 2015-11-17 | Geraghty James A (Director) | Buy | 8,000 | 11.75 | 94,000 |
| 2015-08-14 | Merrifield C Ann (Director) | Buy | 2,000 | 9.87 | 19,740 |
| 2015-08-13 | Merrifield C Ann (Director) | Buy | 1,000 | 9.96 | 9,960 |
| 2015-08-06 | Geraghty James A (Director) | Buy | 12,000 | 10.46 | 125,520 |
| 2015-06-15 | Armstrong Frank M (Director) | Buy | 1,255 | 7.95 | 9,982 |
| 2015-06-09 | Patel Nikin (COO) | Buy | 13,500 | 7.52 | 101,520 |
| 2015-06-01 | Geraghty James A (Director) | Buy | 20,550 | 8.38 | 172,209 |
| 2015-05-11 | Condella Frank Jr (President & CEO) | Option Ex | 9,375 | 4.95 | 46,406 |
| 2015-05-08 | Condella Frank Jr (President & CEO) | Buy | 10,000 | 7.36 | 73,600 |
| 2014-11-20 | Hunter Donald H (Director) | Buy | 1,000 | 5.98 | 5,980 |
| 2014-08-13 | Condella Frank Jr (President & CEO) | Buy | 10,000 | 5.98 | 59,800 |
Insider trading activities including stock purchases, stock sales, and option exercises of CBRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Juniper Pharmaceuticals Inc (symbol CBRX, CIK number 821995) see the Securities and Exchange Commission (SEC) website.